← Albany International overview

Albany International vs Illinois Tool Works: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Albany International Corporation (AIN)

Q3 2026
▲3▼1

Albany's composites growth and strategic review progress offset weak textile demand and CFO uncertainty

  • Record Engineered Composites revenue and new business wins Albany's Engineered Composites segment hit a record $150.8 million in Q2 2026 revenue, up 16% on ramping LEAP, Boeing, and CH-53K programs. New wins like the Pratt & Whitney GTF contract support long-term growth, pushing the stock up on optimism about future sales.

    This is the core positive driver showing strong demand in Albany's growth segment.

  • Strategic review completed, Utah facility retained, guidance raised Albany finished its review of the Salt Lake City plant and decided to keep it after securing new business, a renegotiated Boeing 787 contract, and better Sikorsky CH-53K terms. It raised Q3 adjusted EPS guidance to $1.40-$1.50 from $0.60-$0.70, signaling improved profitability and cash flow starting 2027.

    This is a major new event that directly boosts earnings expectations and removes uncertainty.

  • Boeing 787 contract extended for composite frames Albany Engineered Composites agreed with Boeing to keep making about 300 unique composite fuselage frames for the 787 Dreamliner, a role held since 2014. This locks in steady demand for its composites segment, supporting revenue visibility and investor confidence.

    This new contract extension secures future revenue and reinforces the positive demand trend.

  • CFO medical leave creates leadership uncertainty Albany's CFO Willard Station is on medical leave, and controller Sean Valashinas is acting CFO. Shares fell 4.82% on the news as investors worry about a gap in financial leadership, though the company moved quickly to fill the role temporarily.

    This is a new negative event that weighs on the stock by adding uncertainty.

August 2026
▲3▼1

Albany's composites growth and strategic review progress offset weak textile demand and CFO uncertainty

  • Record Engineered Composites revenue and new business wins Albany's Engineered Composites segment hit a record $150.8 million in Q2 2026 revenue, up 16% on ramping LEAP, Boeing, and CH-53K programs. New wins like the Pratt & Whitney GTF contract support long-term growth, pushing the stock up on optimism about future sales.

    This is the core positive driver showing strong demand in Albany's growth segment.

  • Strategic review completed, Utah facility retained, guidance raised Albany finished its review of the Salt Lake City plant and decided to keep it after securing new business, a renegotiated Boeing 787 contract, and better Sikorsky CH-53K terms. It raised Q3 adjusted EPS guidance to $1.40-$1.50 from $0.60-$0.70, signaling improved profitability and cash flow starting 2027.

    This is a major new event that directly boosts earnings expectations and removes uncertainty.

  • Boeing 787 contract extended for composite frames Albany Engineered Composites agreed with Boeing to keep making about 300 unique composite fuselage frames for the 787 Dreamliner, a role held since 2014. This locks in steady demand for its composites segment, supporting revenue visibility and investor confidence.

    This new contract extension secures future revenue and reinforces the positive demand trend.

  • CFO medical leave creates leadership uncertainty Albany's CFO Willard Station is on medical leave, and controller Sean Valashinas is acting CFO. Shares fell 4.82% on the news as investors worry about a gap in financial leadership, though the company moved quickly to fill the role temporarily.

    This is a new negative event that weighs on the stock by adding uncertainty.

Latest
▲3▼1

Albany's composites growth and strategic review progress offset weak textile demand and CFO uncertainty

  • Record Engineered Composites revenue and new business wins Albany's Engineered Composites segment hit a record $150.8 million in Q2 2026 revenue, up 16% on ramping LEAP, Boeing, and CH-53K programs. New wins like the Pratt & Whitney GTF contract support long-term growth, pushing the stock up on optimism about future sales.

    This is the core positive driver showing strong demand in Albany's growth segment.

  • Strategic review completed, Utah facility retained, guidance raised Albany finished its review of the Salt Lake City plant and decided to keep it after securing new business, a renegotiated Boeing 787 contract, and better Sikorsky CH-53K terms. It raised Q3 adjusted EPS guidance to $1.40-$1.50 from $0.60-$0.70, signaling improved profitability and cash flow starting 2027.

    This is a major new event that directly boosts earnings expectations and removes uncertainty.

  • Boeing 787 contract extended for composite frames Albany Engineered Composites agreed with Boeing to keep making about 300 unique composite fuselage frames for the 787 Dreamliner, a role held since 2014. This locks in steady demand for its composites segment, supporting revenue visibility and investor confidence.

    This new contract extension secures future revenue and reinforces the positive demand trend.

  • CFO medical leave creates leadership uncertainty Albany's CFO Willard Station is on medical leave, and controller Sean Valashinas is acting CFO. Shares fell 4.82% on the news as investors worry about a gap in financial leadership, though the company moved quickly to fill the role temporarily.

    This is a new negative event that weighs on the stock by adding uncertainty.

Illinois Tool Works Inc (ITW)

Q3 2026
▲3▼1

ITW's strong Q2 and record cash returns met by a late 2027 demand warning

  • Q2 beat and raised guidance ITW reported record quarterly operating income of $1.15 billion, with organic growth of 4.5% and earnings per share up 10% to $2.84. Management raised full-year organic sales growth guidance to 3% to 4%, saying demand accelerated across every segment. The stock jumped 5.5% on the news.

    This is the period's biggest positive event and the main reason ITW's price moved up.

  • Bigger dividend and $6 billion buyback ITW raised its dividend 7% to $6.88 a year and authorized a new $6 billion share buyback. Returning cash this way supports the stock price by shrinking the number of shares and rewarding holders, and signals management expects steady cash flow ahead.

    It is a fresh, concrete capital-return decision that supports the share price.

  • Analyst estimate upgrade ITW was upgraded to Zacks Rank #2 (Buy) as analysts nudged up their earnings estimates over the past three months. Rising estimates often pull the share price higher because investors pay for expected future profits, though the expected $11.44 per share is flat versus last year.

    It shows a fresh, if modest, shift in analyst sentiment that can move the stock.

  • JPMorgan downgrade on slowing demand JPMorgan cut ITW to Neutral from Overweight and slashed its price target to $270 from $350, warning that short-cycle industrial demand is slowing into 2027. A lower target and downgrade can weigh on the stock by cooling investor expectations for future growth.

    It is the main counterweight this period and directly explains why the stock could face pressure.

August 2026
▲3▼1

ITW's strong Q2 and record cash returns met by a late 2027 demand warning

  • Q2 beat and raised guidance ITW reported record quarterly operating income of $1.15 billion, with organic growth of 4.5% and earnings per share up 10% to $2.84. Management raised full-year organic sales growth guidance to 3% to 4%, saying demand accelerated across every segment. The stock jumped 5.5% on the news.

    This is the period's biggest positive event and the main reason ITW's price moved up.

  • Bigger dividend and $6 billion buyback ITW raised its dividend 7% to $6.88 a year and authorized a new $6 billion share buyback. Returning cash this way supports the stock price by shrinking the number of shares and rewarding holders, and signals management expects steady cash flow ahead.

    It is a fresh, concrete capital-return decision that supports the share price.

  • Analyst estimate upgrade ITW was upgraded to Zacks Rank #2 (Buy) as analysts nudged up their earnings estimates over the past three months. Rising estimates often pull the share price higher because investors pay for expected future profits, though the expected $11.44 per share is flat versus last year.

    It shows a fresh, if modest, shift in analyst sentiment that can move the stock.

  • JPMorgan downgrade on slowing demand JPMorgan cut ITW to Neutral from Overweight and slashed its price target to $270 from $350, warning that short-cycle industrial demand is slowing into 2027. A lower target and downgrade can weigh on the stock by cooling investor expectations for future growth.

    It is the main counterweight this period and directly explains why the stock could face pressure.

Latest
▲3▼1

ITW's strong Q2 and record cash returns met by a late 2027 demand warning

  • Q2 beat and raised guidance ITW reported record quarterly operating income of $1.15 billion, with organic growth of 4.5% and earnings per share up 10% to $2.84. Management raised full-year organic sales growth guidance to 3% to 4%, saying demand accelerated across every segment. The stock jumped 5.5% on the news.

    This is the period's biggest positive event and the main reason ITW's price moved up.

  • Bigger dividend and $6 billion buyback ITW raised its dividend 7% to $6.88 a year and authorized a new $6 billion share buyback. Returning cash this way supports the stock price by shrinking the number of shares and rewarding holders, and signals management expects steady cash flow ahead.

    It is a fresh, concrete capital-return decision that supports the share price.

  • Analyst estimate upgrade ITW was upgraded to Zacks Rank #2 (Buy) as analysts nudged up their earnings estimates over the past three months. Rising estimates often pull the share price higher because investors pay for expected future profits, though the expected $11.44 per share is flat versus last year.

    It shows a fresh, if modest, shift in analyst sentiment that can move the stock.

  • JPMorgan downgrade on slowing demand JPMorgan cut ITW to Neutral from Overweight and slashed its price target to $270 from $350, warning that short-cycle industrial demand is slowing into 2027. A lower target and downgrade can weigh on the stock by cooling investor expectations for future growth.

    It is the main counterweight this period and directly explains why the stock could face pressure.